Technology & Medicine › Electric age › Penicillin and antibiotics
Salvarsan, the first 'magic bullet'
1910 (Ehrlich, Hata)· Invention or discovery· Germs, drugs & genetics
Well documentedSolid records, physical evidence or scientific consensus.
An arsenic compound that cured syphilis, found in 1909 by Paul Ehrlich and Sahachiro Hata: the first modern drug designed to target a germ.
See it on the Technology & Medicine map →How it works
Paul Ehrlich in Frankfurt saw that some dyes stained germs but not human cells, and imagined 'magic bullets' that would kill germs selectively. His team made and tested hundreds of arsenic compounds. In 1909 Japanese bacteriologist Sahachiro Hata found that compound 606 cured syphilis in infected rabbits. Sold from 1910 as Salvarsan, it was toxic and needed a series of injections, but it worked against a disease that had been nearly incurable. The milder Neosalvarsan followed in 1912.
Why it mattered
Salvarsan proved chemists could design drugs to hit a specific microbe, launching the systematic drug screening that found sulfa drugs and the idea behind chemotherapy.
Think of it like
Like a key cut for one lock: the drug attacks the germ and largely leaves the body's own cells alone.
How we know
Ehrlich and Hata's 1910 book on the drug; records of Ehrlich's institute and the maker Hoechst; early clinical reports from Germany and abroad; Ehrlich's 1908 Nobel Prize, for earlier immunity work.
Still unknown or debated
How many patients were harmed by side effects or bad dosing is uncertain, and Hata's role is often underplayed in Western accounts.
Connections (3)
▸Cinchona bark (quinine) prefigured the targeted cures of Salvarsan, the first 'magic bullet'Mostly agreed
The connection
Cinchona bark was the first medicine known to cure one specific disease, malaria, rather than just easing symptoms. Ehrlich built on that idea: he tried the dye methylene blue against malaria in 1891, then searched systematically for chemicals that would hit a single germ. Salvarsan, against syphilis, was that search's first big success.
When and how
Cinchona reached Europe from the Andes by the 1630s; quinine was isolated in Paris in 1820; Ehrlich worked in Berlin in 1891 and Frankfurt in 1909–10.
How sure are we?
Ehrlich's 1891 methylene blue paper is documented. The link is a line of ideas, a specific cure for a specific disease, rather than shared chemistry.
Debates and open questions
Exactly how quinine kills malaria parasites is still not fully settled, and historians differ on how much quinine, versus dye chemistry, shaped Ehrlich's thinking.
▸Salvarsan, the first 'magic bullet' inspired the chemical search that found Sulfa drugsWell documented
The connection
Paul Ehrlich found Salvarsan by testing hundreds of synthetic compounds, number 606 being the winner, for one that killed the syphilis germ. Domagk used the same approach at Bayer, screening thousands of dyes in infected mice until Prontosil worked in 1932. Ehrlich's idea that dyes could target germs selectively guided both.
When and how
Frankfurt, 1909–10 (Ehrlich and Sahachiro Hata); Bayer's laboratories at Elberfeld, Germany, then part of IG Farben, 1927–35 (Domagk).
How we know
Domagk's program was explicitly modeled on Ehrlich's dye-screening chemistry; both grew from Germany's dye industry, as company and lab records show.
Debates and open questions
Prontosil works only after the body breaks it down; whether Bayer's chemists missed, or kept quiet, that the cheap breakdown product was the real drug is debated.
▸Salvarsan, the first 'magic bullet' pioneered the 'chemotherapy' idea behind Cancer chemotherapyWell documented
The connection
Ehrlich coined 'chemotherapy' for chemicals that hit disease while sparing the body, his 'magic bullet'. He aimed first at germs but also tested compounds against tumors in mice. Cancer drugs from the 1940s pursued his goal: find chemicals that harm cancer cells more than healthy ones.
When and how
Frankfurt, 1900s–1910 (Ehrlich); Yale and Boston, 1940s (Goodman, Gilman and Farber).
How we know
Ehrlich's writings use the word 'chemotherapy', and later cancer researchers cited his magic-bullet ideal explicitly.
Debates and open questions
Early cancer drugs were blunt, harming all fast-dividing cells; targeted drugs closer to Ehrlich's ideal, such as imatinib (2001), came much later, and none is a perfect magic bullet.